indianpharmanetwork's Journal

The medicine Enhertu contains fam-trastuzumab deruxtecan-nxki that is used in treatment of unresectable or metastatic HER2-positive breast cancer. This indication is approved under accelerated approval based on tumor response rate and duration of response. Enhertu is supplied in single-dose vials in 100 mg to administer intravenously. The active ingredient in the vials is trastuzumab deruxtecan with inactive ingredients� L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, and sucrose.�

�

One can buy Enhertu readily in India with several generic medicine suppliers. To know more about Enhertu, dial us at 1800-889-1064.